Ardelyx reported $-26938000 in Net Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbott ABT:US $ 2018M 429M
Amgen AMGN:US $ 1317M 159M
Ardelyx ARDX:US $ -26.94M 1.13M
Astrazeneca AZN:US $ 360M 26M
Biocept BIOC:US $ -2.77M 0.2M
Chimerix CMRX:US $ -23.47M 1.3M
Corcept Therapeutics CORT:US $ 27.41M 4.62M
Curis CRIS:US $ -15.94M 0.17M
Life Technologies LIFE:US $ -12.42M 0.27M
Opko Health OPK:US $ -101.65M 46.22M
Tg Therapeutics TGTX:US $ -40.51M 28.5M
United Therapeutics UTHR:US $ 116M 123.9M
Xoma XOMA:US $ -4670000 2.39M